^
CANCER:
Giant Cell Tumor of Bone
No biomarker
Giant Cell Tumor of Bone
denosumab
Sensitive
:
A1
No biomarker
Tenosynovial Giant Cell Tumor
pexidartinib
Sensitive
:
A1
No biomarker
Chordoma
sorafenib
Sensitive
:
A2
No biomarker
Chordoma
dasatinib
Sensitive
:
A2
No biomarker
Chordoma
YD312
Sensitive
:
A2
No biomarker
Chordoma
sunitinib
Sensitive
:
A2
No biomarker
Chordoma
erlotinib
Sensitive
:
A2
TMB-H
Chordoma
pembrolizumab
Sensitive
:
A2
EGFR expression
Chordoma
lapatinib
Sensitive
:
A2
MSI-H/dMMR
Chordoma
pembrolizumab
Sensitive
:
A2
SMARCB1 negative
Chordoma
tazemetostat
Sensitive
:
C2
PTEN deletion
Chordoma
PDGFR inhibitor
Resistant
:
C4
PTEN deletion
Chordoma
PDGFR inhibitor + HDAC inhibitor
Sensitive
:
C4
H3F3A mutation + ARID2 mutation
Giant Cell Tumor of Bone
denosumab
Resistant
:
C4
AXL underexpression
Chordoma
afatinib
Sensitive
:
D
STK33 underexpression
Chordoma
afatinib
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our